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Uncoupling proteins (UCPs) are mitochondrial inner membrane proteins sustaining an inducible proton conductance. They weaken the proton
electrochemical gradient built up by the mitochondrial respiratory chain. Brown fat UCP1 sustains a free fatty acid (FA)-induced purine nucleotide
(PN)-inhibited proton conductance. Inhibition of the proton conductance by PN has been considered as a diagnostic of UCP activity. However,
conflicting results have been obtained in isolated mitochondria for UCP homologues (i.e., UCP2, UCP3, plant UCP, and protist UCP) where the
FFA-activated proton conductance is poorly sensitive to PN under resting respiration conditions. Our recent work clearly indicates that the
membranous coenzyme Q, through its redox state, represents a regulator of the inhibition by PN of FFA-activated UCP1 homologues under
phosphorylating respiration conditions. Several physiological roles of UCPs have been suggested, including a control of the cellular energy
balance as well as the preventive action against oxidative stress. In this paper, we discuss new information emerging from comparative proteomics
about the impact of UCPs on mitochondrial physiology, when recombinant UCP1 is expressed in yeast and when UCP2 is over-expressed in
hepatic mitochondria during steatosis.
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Uncoupling proteins (UCPs) form a subfamily within the
mitochondrial anion carrier protein family. UCPs reside in the
inner mitochondrial membrane and catalyze a proton conduc-
tance that dissipates the proton electrochemical gradient built up
by the respiratory chain.
UCP1 present in brown adipocytes was believed to be a late
evolutionary acquisition in mammals required for adaptative
thermogenesis [1], until the discovery of a plant UCP in potato
tubers [2]. Since then, UCP1 homologues have been found
throughout mammalian tissues (UCP2 in several tissues, UCP3
in brown adipose tissue and muscle, UCP4 and UCP5 in brain)Abbreviations: FFA, free fatty acids; PN, purine nucleotides; Q, coenzyme
Q, ubiquinone; ROS, reactive oxygen species; UCP, uncoupling protein; ΔΨ,
mitochondrial membrane electrical potential; 2D-DIGE, two-dimensional
differential in-gel electrophoresis
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doi:10.1016/j.bbabio.2006.02.004and the eukaryote world with the exception of fermentative
yeast [3]. Since expression of UCP1 homologues in non-
thermogenic tissues and unicellulars excludes an involvement
in thermogenesis [4–6], their physiological role is still debated.
UCPs are able to share the protonmotive force with ATP
synthase (H+ partitioning) during phosphorylating (state 3)
respiration and partially uncouple electron transport from ATP
synthesis [7]. As a consequence of the energy dissipation, a
consensus role for UCP homologues could be a protection
against reactive oxygen species (ROS) production by decreas-
ing the reduced state of the mitochondrial respiratory chain
[5,6].
Compared to UCP1, the catalytic activity of other UCPs and
its regulation are poorly understood. Activation of UCP1
homologues by free fatty acids (FFA) is currently debated,
although the direct effect of FFA is well documented in
reconstituted systems [8–10]. Moreover, it seems that super-
oxide anion could activate UCPs through lipid peroxidation
products, such as 4-hydroxy-2-nonenal [11,12]. For a long time,
an inhibition of H+ conductance by purine nucleotides (PN) was
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observed for several UCP1 homologues (UCP2, UCP3, plant
UCP) in reconstituted proteoliposomes [8–10]. As in the case of
UCP1, the affinity of UCP1 homologues to PN was estimated to
be in the μM range of concentration [13,14]. However,
conflicting results were obtained with isolated mitochondria,
where the FFA-activated H+ conductance was poorly sensitive
to PN under non-phosphorylating conditions [15–18]. So far,
only the “superoxide-activated” state of UCP1 homologues has
been thought to be inhibited by PN in isolated non-
phosphorylating mitochondria [11,12,19].
Here, we report major progress in the understanding of the
regulation of the activity of UCP1 homologues and new leads to
their physiological roles emerging from recent comparative
mitoproteomic studies.
2. Regulation of uncoupling proteins
The best-characterized uncoupling protein is certainly UCP1
of brown adipose tissue [1,20]. UCP1 sustains a FFA-induced
PN-inhibited H+ conductance that greatly increases the brown
adipose tissue respiration rate in a response to hormonal
stimulus (noradrenaline). The respiratory burst is responsible
for the cold-induced adaptative thermogenesis and is the
consequence of peculiar properties of brown adipose tissue
mitochondria, namely a high capacity of the respiratory chain
and a low capacity of ATP synthase. In both isolated
mitochondria and reconstituted proteoliposome systems,
UCP1 exhibits a wide tolerance towards FFA. Yeast mitochon-
dria containing recombinant UCP1 exhibit the FFA-activated
PN-inhibited H+ conductance under state 4 respiration [21,22].
Although there is some information about in vivo uncoupling
through UCP1 homologues, it is difficult to correlate the
increased UCP-sustained uncoupling to the increased level of
FFA [23], except for hepatocytes from genetically obese ob/ob
mice over-expressing UCP2 [24]. The FFA-activated H+
conductance has also been observed in isolated recombinant
yeast mitochondria containing plant UCP [18], while contra-
dictory results have been obtained with UCP2 and UCP3
expressed in yeast [25–27].
So far, most research has focused on the activation of UCPs
in non-phosphorylating respiring mitochondria (i.e., with a
maximal state 4 ΔΨ). This limits the interpretation of the
physiological regulation of UCPs in vivo, since mitochondria
are ADP-phosphorylating entities (i.e., working at a lowered
state 3 ΔΨ). We have recently shown that in phosphorylating
mitochondria, the mammalian (rat skeletal muscle), protist
(amoeba A. castellanii), and plant (potato tuber) UCPs are able
to decrease the efficiency of oxidative phosphorylation (i.e., the
amount of ADP phosphorylated per oxygen consumed) in the
presence of FFA in μM range concentrations (up to 10 μM)
[15,28–32]. This indicates that UCP1 homologues can be
activated when mitochondria are in a phosphorylating state and
that they can compete with ATP synthase for the protonmotive
force (H+ partitioning).
The binding of PN to a high affinity binding site of UCP1
inhibits the H+ conductance triggered by FFA [33]. As alreadymentioned in Introduction, conflicting observations were
obtained with UCP1 homologues. Recently, we have shown
that PN are also efficient inhibitors of FFA-activated UCP1
homologues in phosphorylating mitochondria (when Q
reduction level is sufficiently oxidized) [29–31]. Namely,
the rat skeletal muscle UCP3 was activated by FFA in state 3
respiration, while its inhibition by PN depended on the redox
state of coenzyme Q [29]. Coenzyme Q is a redox
intermediate of the respiratory chain translocating electrons
from dehydrogenases (i.e., an electron entry) to the
cytochrome pathway and an alternative oxidase (in plants
and protists). Using mitochondria respiring on succinate (plus
rotenone) as an oxidizable substrate, we observed that a PN
(GTP) was not able to inhibit muscle UCP3 under full state 3
respiration (when Q reduction level is high), as no recovery
of the FFA-altered oxidative phosphorylation efficiency was
observed [29]. However, when state 3 respiration was
decreased by n-butyl malonate (an inhibitor of succinate
uptake), a progressive inhibition of FFA-activated muscle
UCP3 by PN was found. This n-butyl malonate induced
decrease of respiration was linearly correlated to the decrease
in the Q reduction level (i.e., Q reduced/Q total) and to a
constant state 3 ΔΨ. Contrarily, if state 3 respiration was
decreased by antimycin A (an inhibitor of complex III), no
inhibition of UCP3 by PN was observed, as the Q reduction
level was increased. Similar results were obtained with
mitochondria from the protist Acanthamoeba castellanii
using succinate (plus rotenone) and external NADH as
oxidizable substrates [30]. Moreover, in A. castellanii
mitochondria isolated from cold-treated cells, where a higher
UCP expression was observed, the PN inhibition of an FFA-
induced proton leak (that was higher) was revealed for the
same values of Q reduction levels as in control mitochondria.
With potato tuber mitochondria [31], although the starting
situation (full state 3 respiration) was different, the results
were finally in accordance with those obtained with rat
muscle and protist mitochondria [29,30]. Indeed, as the initial
Q reduction level of state 3 respiration was quite low, we
observed a full inhibition of FFA-induced UCP activity by PN
without the necessity of state 3 titration with n-butyl malonate
(that still more decreased the Q reduction level) [31]. On the
other hand, an inhibition of state 3 respiration with antimycin
A (that increases the Q reduction level) progressively
cancelled inhibition by PN, which could be restored by the
further titration of state 3 respiration with n-butyl malonate
(that decreases the Q reduction level). These results strongly
suggest that the redox state of Q is a metabolic sensor that
modulates the inhibition of FFA-induced UCP activity by PN
(Fig. 1) in phosphorylating mammalian, protist, and plant
mitochondria [29–31]. Interestingly, in the case of UCP1,
UCP2 and UCP3, coenzyme Q has been previously shown to
be an obligatory factor for their action in reconstituted
systems [34,35]. The finding that in phosphorylating
mitochondria, the redox state of Q modulates sensitivity of
FFA-induced UCP activity to PN (thereby meaning that at a
high Q reduction level UCPs are active) is very important. It
determines a new key-feature of the UCP activity regulation
Fig. 1. Dependence of the FFA-induced UCP1 homologue-mediated H+
conductance in the absence or presence of purine nucleotides on the Q
reduction level in phosphorylating mitochondria. Data from isolated A.
castellanii mitochondria are used [30]. Measurements were made in the
presence of 9 μM linoleic acid (as an example of FFA), and in the absence or
presence of 0.56 mM GTP (as an example of PN). Substrate oxidation was
gradually decreased by increasing concentration of n-butyl malonate with
succinate or by decreasing the concentration of NADH (with external NADH).
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phosphorylating mitochondria) and it provides an explanation
of how UCPs could be activated in vivo despite the amount
of PN present in the cell (in mM concentration). Moreover,
the occurrence of this feature in mammals, plants and protists
supports the universality of this new regulatory mechanism.
Regulation by the Q reduction level reconciles the conflicting
results obtained in reconstituted systems and isolated
mitochondria, as it means the PN binding site operational in
reconstituted systems and also the unlike PN inhibition in
non-phosphorylating mitochondria, where the Q reduction
level is high. Furthermore, through its redox state, coenzyme
Q represents the ideal regulator as it is directly involved in
sensing the ATP demand through the redox state of the
respiratory chain. Namely, when ATP demand is high and an
oxidizable substrate availability is low, PN inhibition could be
turned on through a low reduced state of Q, leading to
inactive UCP and efficient ATP synthesis. On the other hand,
at low ATP demand and at a high oxidizable substrate
availability, the Q reduced state is high and active UCP could
work as a safety valve to avoid overload in reducing power
and in phosphate potential, allowing the Krebs cycle carbon
flux and other anabolic pathways to proceed. Altogether,
these observations strongly support the idea of UCPs as
controllers of the energy balance of the cell.
3. Uncoupling proteins at a proteomic glance
Although comparative proteomics yield a rather static
picture, it can adequately reflect the state of the mitoproteome
in given conditions and then can be used to identify alterations
of the mitoproteome in the course of the cell life. We
investigated the use of large-scale proteomic surveys to obtain
new insights into the impact of UCPs on the mitochondrial
physiology. Considering that UCP content can vary in manycircumstances, we started studying mitochondria in which UCP
content is changed in order to depict the relationship between
UCP and the mitoproteome.
Nowadays, the study of mitochondrial proteomes relies on
gel-based approaches with high resolution 2D gel electropho-
resis, which is recognized as the most straightforward
proteomic tool for comparative profiling of soluble protein
patterns [36]. In order to eliminate the substantial gel-to-gel
variability, we chose the two-dimensional differential in-gel
electrophoresis (2D-DIGE) that has been developed to enable
visualization of multiple protein samples on a single 2D gel
[37]. This multiplexing technology allows the avoidance of get-
to-gel variations and by the use of internal standard it allows
inter-gel variations to be minimised. 2D-DIGE also allows an
accurate quantification of the protein expression differences
supported by statistical analysis. It is based on a pre-
electrophoretic labelling of protein samples with three distinct
and spectrally resolvable fluorescent dyes, CyDyes (N-hydroxy
succinimide derivatives), one being used to label a pooled
sample (internal standard) containing equal amounts of the two
other independent samples that are to be compared [38].
What can comparative proteomics do for our understanding
of the regulation and physiological role of UCPs? Yeast over-
expressing UCP1 (10 μg/mg of total mitochondrial proteins)
exhibits only a slight growth defect (30% increase in the
generation time) [21,22]. Accordingly, we hypothesized that the
yeast can adapt its mitochondrial proteome in response to the
UCP1-sustained uncoupling in order to save its “purpose of
life”, namely cell growth. We performed a 2D-DIGE compar-
ative proteomic survey of mitochondrial proteomes containing
two levels of UCP1 (1 or 10 μg of UCP1 per mg of
mitochondrial proteins, LE and HE, respectively) versus control
mitochondria [22]. The LE strain adapted very efficiently (no
growth effect) its mitochondrial proteome in response to the low
expression level of UCP1. In this strain, the energy-dissipating
action of UCP1 was countered by a moderate over-expression
of ATP synthase, which promotes the H+ partitioning in favour
of energy conservation. There were also changes in the content
of other proteins related to energy metabolism. For example, up-
regulation of isocitrate dehydrogenase that controls the Krebs
cycle flux and down-regulation of NADH cytochrome b5
reductase that consumes externally produced NADH were
observed. The mitochondrial adaptation allows the LE strain to
avoid suffering from ATP limitation and as a consequence from
growth defect. On the other hand, in the HE strain, growth
defect was visible although 2D-DIGE analysis revealed a wider
reaction of the cell at the level of mitochondrial proteome. As a
large scale response, the total mitochondrial mass in the HE
stain was almost twice that of the control and LE strains.
Specific adaptation of the mitochondrial proteome in response
to the high level over-expression of UCP1 involved the up-
regulation of ATP synthase (higher than in the LE strain),
complex III, isocitrate dehydrogenase, and the down-regulation
of NADH cytochrome b5 reductase (Fig. 2, lower part).
Altogether, these changes in the mitochondrial proteome
indicate that the HE yeast fights for its growth by adjusting
the mitochondrial energy metabolism but unsuccessfully as the
Fig. 2. Information from comparative proteomic analysis on the impact of UCPs on the mitochondrial physiology, when recombinant UCP1 is expressed in yeast and
when UCP2 is over-expressed in hepatic mitochondria during steatosis. ETF, electron transferring flavoproteins; O2
U−, superoxide anion; ROS, reactive oxygen species;
SOD, superoxide dismutase.
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yeast to the presence of UCP1 has a deep impact on the
mitochondrial ROS production due to a higher metabolic
turnover [22]. Namely, ROS production is increased when
metabolic turnover increases due to an increase in the
respiratory chain enzyme levels. Mitochondrial ROS formation
depends on the redox state of respiratory chain electron carriers
(namely, on the balance between electron entry and exit into/
from coenzyme Q). Moreover, a higher metabolic turnover has a
secondary influence on the mitochondrial proteome, as up-
regulation of superoxide dismutase that catalyses the removal of
superoxide anion and of aconitase that is irreversibly inactivated
by superoxide anion was observed.
Hepatocytes during steatosis were our second mitochondrial
model to study the impact of elevated UCP level on
mitochondrial physiology. Obesity results from a long-term
energy-imbalance between nutrient-derived energy uptake and
energy expenditure. In hepatocytes from genetically obese ob/
ob mice, UCP2 mRNA is ~6-fold increased and the proteinbecomes visible by immunohistochemistry [24]. The ATP
synthesis efficiency is affected, whereas no change in the ATP
synthase content is detected [39]. Moreover, the increase in
UCP2 can be correlated to an increase in FFA content since ob/
ob hepatocytes suffer from steatosis [40], and since the ucp2
gene possesses upstream activated elements that respond to a
high fatty acid content [23]. Our proteomic survey indicates that
the response to steatosis concerns pathways involved in the
generation (β-oxidation) and in the consumption (Krebs cycle,
gluconeogenesis, ketogenesis) of acetyl-CoA [41] (Fig. 2, upper
part). We found large increases in all key-enzymes of the fatty
acid oxidation pathway and of the Krebs cycle, which lead to a
high reducing substrate availability (NADH and FADH2), and
in proteins of the respiratory chain that consume the NADH/
FADH2 reducing equivalents (complex I and electron-transfer
flavoprotein oxidoreductase). We found no evidence of changes
in either ATP synthase or in complexes III and IV. The
mitoproteome adaptations occurring during steatosis lead to a
higher electron input into the respiratory chain and to a higher Q
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UCP2 by PN. Together with a high FFA availability and an
increase in UCP2 content, the resulting increase in uncoupled
respiration would be a very appropriate way to decrease
substrate overload and to facilitate the Krebs cycle and anabolic
pathways. This increased metabolic turnover due to an increase
in respiratory chain enzyme levels leads to a higher production
of ROS, although UCP2 is up-regulated [39].
4. Conclusions
In the face of discoveries that UCPs are efficiently active
during phosphorylating respiration and that their activity is
regulated by the redox state of Q, it is justified to consider that
UCPs play an important role in maintaining energy balance
under phosphorylating conditions. The involvement of UCPs in
the control of the cellular energetic status means that prevention
of superoxide anion generation could be only an obligatory
outcome of the respiration uncoupled by UCPs. This function is
more likely to occur at a highΔΨ in resting mitochondria, while
the increasing concentration of UCP is accompanied with
proteomic changes that increase basal ROS production through
a higher metabolic turnover. It is noteworthy that the
involvement in both energy balance and ROS protection
could reflect a dual role of UCPs depending on the
mitochondrial metabolic status.
The present work shows that an inseparable interplay
between UCPs and energy metabolism also exists at the
proteomic level. On the one hand, in genetically-induced obese
mice, hyperphagia triggers a substrate overload and a higher
ROS production. To compensate for the energetic imbalance, an
adaptative response occurs at the mitoproteome level that
involves the up-regulation of enzymes resulting in a higher
reducing substrate availability and of UCP2, which is an
energetic spendthrift system. On the other hand, over-
expression of UCP1 in yeast has an impact on ATP synthesis
yield due to proton partitioning, resulting in a higher cellular
ATP demand. To compensate for this energetic imbalance, an
adaptative response occurs at the mitoproteome level that
involves an up-regulation of ATP synthase and of enzymes
implied in energy conservation. Moreover, as a result of the
adaptative modification of the yeast proteome in favour of
energy conservation, the increase in the metabolic turnover
stimulates ROS generation. These results enlighten a complex
cross-talk between mitochondria and the nucleus that regulates
the expression of key-enzymes involved in the homeostasis of
energy metabolism. These enzymes are consequently adjusted
in response to various mitochondrial metabolic statuses,
reflecting the tremendous plasticity of the mitochondrial
proteome.
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